AURAVAX THERAPEUTICS

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MCALLISTER & QUINN, LLC	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	5
Budget/Appropriations	Budget/Appropriations	5
Defense	Defense	5

Bills Explicitly Cited (6)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: $50,000

Matched citations: S. 2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: $50,000

Matched citations: S. 2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: $50,000

Matched citations: S. 2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: —

Matched citations: S. 2572

Show 2 more cited filings

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: —

Matched citations: S. 2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: MCALLISTER & QUINN, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Client expense: — · Firm income: —

Matched citations: S. 2572

Source: Senate LDA

AURAVAX THERAPEUTICS — Lobbying Disclosure | Poliscope